Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10620540rdf:typepubmed:Citationlld:pubmed
pubmed-article:10620540lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C0019061lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C0024297lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:10620540lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:10620540pubmed:issue1lld:pubmed
pubmed-article:10620540pubmed:dateCreated2000-1-12lld:pubmed
pubmed-article:10620540pubmed:abstractTextVerotoxin-producing Escherichia coli (VTEC) cause hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS). The aim of this study was to compare the circulating levels of transforming growth factor-beta 1 (TGF-beta1), T helper (T(H))1 (interferon [IFN]-gamma, interleukin [IL]-2), and T(H)2-associated lymphokines (IL-4, IL-13) in children with uncomplicated Escherichia coli O157:H7 HC and patients who developed HUS. Circulating levels of IL-2, IL-4, and IL-13 were undetectable, and those of IFN-gamma were low and comparable among groups. Concentrations of TGF-beta1 were higher in children with uncomplicated O157:H7 HC than among those who developed HUS (934 +/- 680 versus 514 +/- 497 pg/mL, respectively; P < 0.04). The circulating levels of TGF-beta1 were also higher among children who did not take antidiarrheal agents (P < 0.008) and those who have been immediately discharged from the emergency room (P < 0.03). Our results did not show an imbalanced T(H)1/T(H)2-associated lymphokine response during the development of HUS. Increased circulating levels of TGF-beta1 in children with milder O157:H7 or uncomplicated HC most likely reflect appropriate intestinal tissue repair mechanisms rather than a remote systemic endocrine effect on the kidneys.lld:pubmed
pubmed-article:10620540pubmed:languageenglld:pubmed
pubmed-article:10620540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10620540pubmed:citationSubsetIMlld:pubmed
pubmed-article:10620540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10620540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10620540pubmed:statusMEDLINElld:pubmed
pubmed-article:10620540pubmed:monthJanlld:pubmed
pubmed-article:10620540pubmed:issn1523-6838lld:pubmed
pubmed-article:10620540pubmed:authorpubmed-author:SeidmanEElld:pubmed
pubmed-article:10620540pubmed:authorpubmed-author:MariscalcoM...lld:pubmed
pubmed-article:10620540pubmed:authorpubmed-author:ProulxFFlld:pubmed
pubmed-article:10620540pubmed:authorpubmed-author:TurgeonJ PJPlld:pubmed
pubmed-article:10620540pubmed:authorpubmed-author:LitalienCClld:pubmed
pubmed-article:10620540pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10620540pubmed:volume35lld:pubmed
pubmed-article:10620540pubmed:ownerNLMlld:pubmed
pubmed-article:10620540pubmed:authorsCompleteYlld:pubmed
pubmed-article:10620540pubmed:pagination29-34lld:pubmed
pubmed-article:10620540pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:meshHeadingpubmed-meshheading:10620540...lld:pubmed
pubmed-article:10620540pubmed:year2000lld:pubmed
pubmed-article:10620540pubmed:articleTitleCirculating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome.lld:pubmed
pubmed-article:10620540pubmed:affiliationDepartment of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, Canada. sip@point-net.comlld:pubmed
pubmed-article:10620540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10620540pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10620540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10620540lld:pubmed